Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036572 (
seizures
)
80,221
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Heightened neural excitability in infancy and childhood results in increased susceptibility to
seizures
. Such early-life
seizures
are associated with language deficits and autism that can result from aberrant development of the auditory cortex. Here, we show that early-life
seizures
disrupt a critical period (CP) for tonotopic map plasticity in primary auditory cortex (A1). We show that this CP is characterized by a prevalence of "silent," NMDA-receptor (NMDAR)-only, glutamate receptor synapses in auditory cortex that become "unsilenced" due to activity-dependent AMPA receptor (AMPAR) insertion. Induction of
seizures
prior to this CP occludes tonotopic map plasticity by prematurely unsilencing NMDAR-only synapses. Further, brief treatment with the AMPAR antagonist
NBQX
following
seizures
, prior to the CP, prevents synapse unsilencing and permits subsequent A1 plasticity. These findings reveal that early-life
seizures
modify CP regulators and suggest that therapeutic targets for early post-
seizure
treatment can rescue CP plasticity.
...
PMID:Early Seizures Prematurely Unsilence Auditory Synapses to Disrupt Thalamocortical Critical Period Plasticity. 3056 58
<< Previous
1
2
3
4
5
6
7
8
9
10